13 Most Promising Penny Stocks Under $5
On August 12, Jill Carey Hall, BofA Securities head of US small and mid-cap strategy, joined 'The Exchange' on CNBC to discuss the outlook for small caps, amidst their underperformance.
Clover Health Investments Corp. (CLOV)
Market is closed
Sector: Hospital & Medical Service Plans
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 10,493,600 | $29,277,144 | -5% | 0.04% |
| 2. | Citadel Investment Group Ken Griffin | 3,530,371 | $9,849,735 | +104% | 0% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 3,523,047 | $9,829,302 | -24% | 0.01% |
| 4. | GMT Capital Thomas E. Claugus | 1,305,200 | $3,641,508 | 0.15% | |
| 5. | Millennium Management Israel Englander | 1,058,215 | $2,952,420 | -82% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.59 | 14,500 | $37,555.00 | 29,610 | 2025-08-13 | Filing | |
| $2.60 | 12,000 | $31,200.00 | 27,600 | 2025-08-13 | Filing | |
| $2.17 | 31,980 | $69,396.60 | 1,856,247 | 2025-08-08 | Filing | |
| $2.24 | 415,000 | $929,600.00 | 1,824,267 | 2025-08-07 | Filing | |
| $1.88 | 531,700 | $999,596.00 | 1,409,267 | 2024-08-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.89 | 6,823 | $19,718.47 | 3,261,485 | 2025-08-04 | Filing | |
| $3.32 | 91,197 | $302,774.04 | 1,403,701 | 2025-07-23 | Filing | |
| $3.29 | 118,600 | $390,194.00 | 1,494,898 | 2025-07-22 | Filing | |
| $3.26 | 15,203 | $49,561.78 | 1,613,498 | 2025-07-08 | Filing | |
| $2.85 | 2,012 | $5,734.20 | 3,297,821 | 2025-07-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 30,396,991 | $84,807,604 | 0% | |
| 2. | 24,246,034 | $67,646,435 | 0% | |
| 3. | 9,843,349 | $27,466,720 | 0% | |
| 4. | 7,507,390 | $20,945,618 | 0% | |
| 5. | 4,463,811 | $12,454,033 | 0.01% |
News See All
12 Best Healthcare Stocks to Buy Under $30
Mizuho health care sector strategist Jared Holz made an appearance on CNBC's "The Exchange" on July 21 to discuss the challenges facing the healthcare industry and whether there are any opportunities ...
Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2025 Earnings Call Transcript
Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2025 Earnings Call Transcript August 5, 2025Clover Health Investments, Corp. reports earnings inline with expectations.
Clover Health (CLOV) Announced a New Pharmacy Pilot Program in New Jersey
Clover Health Investments, Corp. (NASDAQ:CLOV) is one of the Best American Penny Stocks to Buy According to Analysts. On July 9, Clover Health Investments, Corp.
11 Best American Penny Stocks to Buy According to Analysts
On July 19, Bailard released its Q2 2025 Small Cap Value Strategy report. The report highlights that in early April, fears of trade wars pushed the US equity markets near bear market territory.
13 Best Healthcare Stocks to Buy Under $10
On June 27, Tiffany McGhee, CEO of Pivotal Advisors, appeared on CNBC to talk about the best course of action for investors amid current market dynamics.
Clover Health (CLOV) Joins Russell 3000 Index, Boosting Visibility
Clover Health Investments, Corp. (NASDAQ:CLOV) is one of Goldman Sachs’ top penny stock picks. On June 30, Clover Health announced its inclusion in the Russell 3000 Index.
Goldman Sachs Penny Stocks: Top 12 Stock Picks
In a June 24, 2025, podcast, Goldman Sachs’ Christian Mueller-Glissmann and Alexandra Wilson-Elizondo examined the dynamics driving markets.
Craig-Hallum Reiterates a Buy Rating on Clover Health Investments (CLOV), Sets a $6 PT
Clover Health Investments, Corp. (NASDAQ:CLOV) is one of the 13 Stocks Under $5 With High Upside Potential.
13 Stocks Under $5 With High Upside Potential
On July 1, Ralph Schlosstein, Evercore chairman emeritus and BlackRock co-founder, appeared on CNBC's 'Closing Bell Overtime' to discuss his outlook for markets heading into the second half of 2025.